Key statistics
As of last trade, Lexaria Bioscience Corp (LEXX:NAQ) traded at 3.17, 272.60% above the 52 week low of 0.85 set on Oct 09, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 3.17 |
---|---|
High | 3.28 |
Low | 3.06 |
Bid | 3.13 |
Offer | 3.17 |
Previous close | 3.19 |
Average volume | 95.64k |
---|---|
Shares outstanding | 15.81m |
Free float | 14.58m |
P/E (TTM) | -- |
Market cap | 50.43m USD |
EPS (TTM) | -0.4455 USD |
Data delayed at least 15 minutes, as of Oct 07 2024 17:10 BST.
More ▼
Announcements
- Lexaria Bioscience Corp. (NASDAQ: LEXX) Proprietary Drug-Delivery System Improves Way Molecules Enter Bloodstream
- Lexaria Bioscience Corp. (NASDAQ: LEXX) Improves Delivery, Efficacy of GLP-1 Agonists Through Proprietary Drug-Delivery Platform
- Lexaria Bioscience Corp. (NASDAQ: LEXX) Expands Studies of Proprietary Platform in Multibillion-Dollar GLP-1 Drug Space
- Lexaria Bioscience Corp. (NASDAQ: LEXX) Evaluating Proprietary Drug-Delivery Platform for Improved Efficacy of GLP-1 Drugs